Back
The Carlyle Group Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
80
CG
The Carlyle Group Inc.
Last Price:
$60.89
Seasonality Move:
0.65%
Buy
61
LYEL
Lyell Immunopharma, Inc.
Last Price:
$37.17
Seasonality Move:
-16.78%
Buy
80
The Carlyle Group Inc. (CG)
is a Buy
Is The Carlyle Group Inc. a Buy, Sell or Hold?
-
The current The Carlyle Group Inc. [CG] share price is $60.92. The Score for CG is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
CG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $37.33. The Score for LYEL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CG Stock Price Chart
What is The Carlyle Group Inc.'s stock price today?
-
The The Carlyle Group Inc. share price today is $60.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CG is experiencing selling pressure, which indicates risk of future bearish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $37.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
CG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.45 | Buy |
| Relative Strength Index (14 RSI): | 65.26 | Buy |
| Chaikin Money Flow: | -2129391 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.93 - 59.29) | Buy |
| Bollinger Bands (100): | (54.9 - 64.64) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.24 | Buy |
| Relative Strength Index (14 RSI): | 78.97 | Buy |
| Chaikin Money Flow: | -246560 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.8 - 33.24) | Buy |
| Bollinger Bands (100): | (10.76 - 24.28) | Buy |
CG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.12 | Buy |
| 20-day SMA: | 57.23 | Buy |
| 50-day SMA: | 55.79 | Buy |
| 200-day SMA: | 53.29 | Buy |
| 8-day EMA: | 59.5 | Buy |
| 20-day EMA: | 57.76 | Buy |
| 50-day EMA: | 57.16 | Buy |
| 200-day EMA: | 54.98 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34 | Buy |
| 20-day SMA: | 29.06 | Buy |
| 50-day SMA: | 22.08 | Buy |
| 200-day SMA: | 13.64 | Buy |
| 8-day EMA: | 33.98 | Buy |
| 20-day EMA: | 29.78 | Buy |
| 50-day EMA: | 23.99 | Buy |
| 200-day EMA: | 17.62 | Buy |
The Carlyle Group Inc. Earnings Growth & CG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $0.74 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
The Carlyle Group Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||